Latest news, reports, and more from the RedChip Nation.
 
 
 >
Genetic Technologies (NASDAQ: GENE) Signs MoU with the Translational Genomics Research Institute
 
 

Genetic Technologies (NASDAQ: GENE), a provider of world-leading genetic risk assessment test products, signed a Memorandum of Understanding (MoU) with the Translational Genomics Research Institute (TGen) of Phoenix, Arizona.

 

Why It Matters: TGen is affiliated with City of Hope in Duarte, California, a world-renowned independent research and treatment center for cancer, diabetes, and other life-threatening diseases. Genetic Technologies and TGen have agreed to collaborate on the commercialization strategy and infrastructure development for a suite of risk tests to be launched in the US market.

 

Key Quote: “We are excited to be working with such a prestigious organization as TGen in bringing our current and developing future polygenic risk tests to the US market.” – Dr. Paul Kasian, Chairman

 

What’s Next: With 20-years’ experience bringing genomics products to market and new opportunities in China and the US, Genetic Technologies is ideally positioned for success.

 

Disclosure

Genetic Technologies (NASDAQ: GENE) is a client of RedChip Companies, Inc. GENE agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.

 
 
 
 >
GSRX Industries (OTCQB: GSRX) Announces Major Milestones in California and Puerto Rico
 
 

GSRX Industries (OTCQB: GSRX) made several major announcements over the past week. In California, the company received its provisional retailer license and a temporary distribution license for adult-use and medicinal cannabis products. In Puerto Rico, the company’s sixth dispensary passed its final inspection and will commence operations upon receipt of its operating permit. On Monday, the company announced its Pure and Natural CBD brand became the exclusive CBD sponsor for country music songwriter and recording artist Cale Dodd’s 2019 US tour.

 

Key Quote: "I am really happy to have Pure and Natural onboard as a sponsor of my tour! Life on the road can be very demanding both physically and mentally but having Pure and Natural products with me helps to maintain my overall health. My band and I use the products daily and I consider Pure and Natural to be the best CBD products on the market today. I hope my fans check out all the great non-THC CBD products over at GetPureAndNatural.com.” – Cale Dodd, singer

 

Disclosure

GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.

 
 
 
 >
Learn About MYnd Analytics (NASDAQ: MYND) Innovative Big Data-Driven Telemedicine Solution for Behavioral Health Treatment and the Company's Acquisition of Emmaus and Its FDA-approved Sickle Cell Treatment in Exclusive Webinar Replay
 
 

Featuring CEO Patrick Herguth & Chairman Robin L. Smith

 

Last week's webinar includes recent developments, key industry trends and growth drivers, as well as insight regarding the Company's acquisition of Emmaus and its FDA-approved sickle cell treatment.

 

The Backstory: MYnd Analytics (NASDAQ: MYND), with its wholly owned subsidiary Arcadian Telepsychiatry Services, LLC, is a technology-enabled telepsychiatry and teletherapy company that provides enhanced access to behavioral health services, improves patient outcomes and helps lower the costs associated with behavioral health issues. The MYnd Psychiatric EEG Evaluation Registry (PEER) is a predictive analytics decision support tool that helps physicians reduce trial and error treatment for behavioral health conditions. PEER provides the physician a personalized care plan with recommended treatment options based on a patient’s unique brain markers, reducing treatment time and treatment costs. Arcadian Telepsychiatry Services, LLC provides a suite of complementary telemedicine services that can be combined with PEER, including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. MYnd’s customers include major health plans, health systems, and community-based organizations. To read more about the benefits of this patented technology for patients, physicians and payers.

 

Disclosure

MYnd Analytics (NASDAQ: MYND) is a client of RedChip Companies, Inc. MYND agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services.

 
 
 
 >
Digital Ally (NASDAQ: DGLY): Patent Office Approves Four New Patents for Digital Ally
 

 

Digital Ally (NASDAQ: DGLY), which develops, manufactures and markets advanced video surveillance products for law enforcement, homeland security and commercial applications, announced its latest innovations for law enforcement video.

 

Four new patents protecting various technology for law enforcement video will be issuing in the near future. The pioneering technology of the ‘396 Patent provides “marking” functionality to law enforcement officers who need to mark a video to allow for easy identification of an important event in the recording.

 

Key Quote: “We have the best engineers in the industry. Out of our humble beginnings in Lenexa, Kansas, our engineers have repeatedly shown that we can out-innovate the biggest competitors in the industry.” Digital Ally’s CEO, Stanton Ross

 

The Backstory: Digital Ally, headquartered in Lenexa, KS, specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.

 

Disclosure

Digital Ally (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.

 

 
 
 
 >
RADA Electronic Industries Ltd. (NASDAQ: RADA) Announces More Than $6 Million in New Orders in the Past Month
 

 

Out of these new orders, $5 million were for RADA’s software-defined AESA radars for international counter UAV solutions.

 

The majority of these were initial orders from new defense customers, which possess significant future potential for repeated follow-on orders. There were also repeated orders from existing defense customers, which are expanding their deployments of their systems that incorporate RADA’s radars.

 

Over $1 million were follow-on orders for RADA’s legacy avionics, including digital video recorders and ongoing maintenance orders for RADA’s wide installment base of core avionics for military airborne platforms.

 

Key Quote: “To date, we have seen good momentum of new orders, especially for our tactical radars business. RADA is currently in a strong growth phase. These orders substantiate and make us confident with our forecast of over $40 million in revenues for 2019, implying growth of over 40% year-over-year,” said RADA’s CEO, Dov Sella

 

The Backstory: RADA Electronic Industries Ltd., an Israel-based defense electronics company, specializes in the development, production, and sales of Tactical Land Radars for Force and Border Protection, and Avionics Systems (including Inertial Navigation Systems) for fighter aircraft and UAVs.

 

 
 
 
 
Quote of the Week
 
"An investment in knowledge pays the best interest."
- Benjamin Franklin
 
 
 
Lesson of the Week
 
Learn to let your winners run.
Read More
 
 
 
 
Latest Videos
 
 
 
 
This Week on RedChip TV: 3 Small-Cap Stocks to Own in 2019
 
Watch the latest episode of the RedChip Money Report featuring interviews with executives from MYnd Analytics (NASDAQ: MYND), GSRX Industries (OTCQB: GSRX), and Electra Meccanica (NASDAQ: SOLO).
 
Watch Now
 
 
 
 
Cuentas Webinar
 
Exclusive investor webinar with Cuentas' President & COO.
 
Watch Now
 
 
 
 
MYnd Analytics: Technology-Enabled Behavioral Heath Services
 
Exclusive interview with MYnd Analytics (NASDAQ: MYND) Chairman of Board Robin Smith. MYND’s telemedicine platform complimented by its behavioral health services technology addresses a combined market in excess of $130 billion. Also, MYND announced a merger agreement with Emmaus Life Sciences. Emmaus has developed the first FDA-approved drug for the treatment of sickle cell disease. The FDA-approved drug addresses a $3 billion worldwide market, with more than 20 million people suffering from sickle cell disease globally
 
Watch Now
 
 
 
 
Rapidly Growing Green Stock in a Multi-Billion-Dollar Market
 
Exclusive interview with GSRX Industries' Chairman Christian Briggs, who discusses the company's rapid growth in the markets for legal medical/recreational marijuana and CBD.
 
Watch Now
 
 
 
 
Sharps Provensa: New Smart Safety Syringe from Sharps Technology
 
Sharps Technology, is an innovative medical device company, introducing a portfolio of new safety syringes and safety products with a patented single-use mechanism. This game-changing sheath technology is designed to eliminate infectious needlestick injuries.
 
Watch Now
 
 
 
 
Marker Therapeutics: Next Major Leap in T Cell-Based Immunotherapies for Cancer
 
Exclusive interview with Marker Therapeutics’ (NASDAQ: MRKR) Chief Development Officer Dr. Juan Vera. MRKR is in multiple active Phase 2 clinical trials in the $100+ billion market for immunotherapy cancer drugs. MRKR’s Multi-Antigen Targeted Cell Therapy Platform and Peptide Vaccine Portfolio has the potential to disrupt the CAR-T and TCR filed therapies.
 
Watch Now
 
 
 
 
Electra Meccanica: Sales Growing for Innovative 1- and 2-Seat Electric Vehicles
 
Exclusive interview with Electra Meccanica Vehicles’ (NASDAQ: SOLO) Founder & CEO Jerry Kroll. Drawing on a 59-year history of designing, building and delivering high end specialty cars, SOLO has designed and built the innovative, all electric SOLO, single-seater electric vehicle. The Company began delivering electric vehicles in 2018 and booked in excess of 60,000 pre-orders. The Company expects to deliver $77M worth of cars in 2019.
 
Watch Now
 
 
 
 
Tenax Therapeutics (NASDAQ: TENX): Near-Term Phase 2 Results Expected to Drive Stock
 
Exclusive interview with Tenax Therapeutics (NASDAQ: TENX) CEO Anthony Ditonno.TENX is expected to report Phase 2 results for its pulmonary hypertension treatment by year end. Its innovative treatment is based on an established compound, approved in 60+ countries and cited in 1000+ publications, which provides a strong foundation that de-risks the development opportunity.
 
Watch Now
 
 
 
 
Polar Power: Innovative Power Solutions for Critical Applications
 
Exclusive interview with Polar Power (NASDAQ: POLA) CEO Arthur Sams. POLA is expected to report record revenue for Q4 2018, driven by increased production capacity and service infrastructure. Revenue growth is expected to accelerate in 2019.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
A recent decline in interest rates drove mortgage application volume up 28% in the final week of March.
Read More
 
 
Weekly Index Performance
 
Small caps led the major indexes higher last week, up more than 2.5%.
Read More
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.